Treatment Choice and Quality of life for Men with Early-Stage Prostate Cancer

Principal Investigator:
Ingrid Oakley-Girvan, Ph.D.
Scott Ramsey, M.D., Ph.D. (Fred Hutchinson Cancer Research Center), Steven Zeliadt, Ph.D. (Fred Hutchinson Cancer Research Center), Ann Hamilton, Ph.D., and David Penson, M.D. (University of Southern California)
Funding Source:
National Cancer Institute Surveillance, Epidemiology and End Results Program
Funding Period:
Study Website:
Many men are faced with a difficult choice for their prostate cancer treatment.  How they weigh information from friends, family and clinicians in making this treatment decision was not previously well documented.  Satisfaction with care has also been an area of potential disparity in specific communities that may be related to difference in information provision during the treatment decision process.  This study helped determine factors that influence treatment choice for men with localized prostate cancer.  We focused on the time of the decision for initial treatment as well as measures of prostate cancer-specific and general quality of life (QOL). We asked men to complete a questionnaire prior to treatment initiation, 6 months later and 5 years later.  Analysis of the five-year data is in process.

© Cancer Prevention Institute of California